Bringing AI to the complex world of healthcare data, Dyad has announced a $10.0M Series A funding round. The company specializes in transforming unstructured clinical information into actionable insights, aiming to make value-based care both more efficient and financially sustainable.
Dyad's proprietary Semantic AI technology, which integrates clinical NLP, knowledge graphs, and machine learning, automates critical administrative workflows from clinical coding to quality measurement. Its products, including BetterLetter for UK primary care and BetterQuality for Medicare Advantage, are designed to boost efficiency, compliance, and patient outcomes for providers and payers.

















.png&w=3840&q=75)